首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Design and synthesis of a novel BODIPY-labeled PSMA inhibitor
Institution:1. Department of Chemistry, Stony Brook University, Stony Brook, NY, United States;2. Institute of Chemical Biology and Drug Discovery, Stony Brook University, Stony Brook, NY, United States
Abstract:Prostate-specific membrane antigen (PSMA) is a zinc-bound metalloprotease which is highly expressed in metastatic prostate cancer. It has been considered an excellent target protein for prostate cancer imaging and targeted therapy because it is a membrane protein and its active site is located in the extracellular region. We successfully synthesized and evaluated a novel PSMA ligand conjugated with BODIPY650/665. Compound 1 showed strong PSMA-inhibitory activity and selective uptake into PSMA-expressing tumors. Compound 1 has the potential to be utilized as a near infrared (NIR) optical imaging probe targeting PSMA-expressing cancers.
Keywords:Prostate cancer  PSMA  BODIPY  Optical imaging
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号